Effects of goal-directed administration of ropivacaine and sufentanil in Epidural Labor Analgesia at different stages of labor

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045066

Enrollment

Unknown

Registered

2021-04-04

Start date

2021-04-15

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing vaginal delivery

Interventions

Group A:epidural background 8ml/h 0.125%Ropivacaine+0.4ug/ml sufentanil in the first and second term

Group B:epidural background 8-12ml/h 0.125% Ropivacaine+0.4ug/ml sufentanil in the first term and 8-12ml/h 0.8ug/ml sufentanil in the second term

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: full-term nulliparous women.

Exclusion criteria

Exclusion criteria: 1.Significant medical or obstetric morbidity; 2.History of allergy to Ropivacaine; 3.Contraindication for epidural aneshtesia.

Design outcomes

Primary

Measure	Time frame
Patient Controlled Analgesia times;Local anesthetic dosage;VAS score;Time of first and second term;Blood gas analysis of neonates;	—

Secondary

Measure	Time frame
Side effects;	—

Countries

China

Contacts

Public ContactWei Changna

Jiaxing Maternity and Child Health Care Hospital (Women and Children Affiliated Hospital, Jiaxing University)

544631360@qq.com+86 18267382732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026